Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine ...

After a clinical exam of her symptoms at the leading movement disorder clinic in Toronto, Mathur was diagnosed with Parkinson’s disease at the age of 27. Since there is no cure for Parkinson’s ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

Bengaluru: HCG Cancer Centre, Bangalore, has used the CyberKnife S7 system to treat a 75-year-old man with Parkinson’s disease. This is the first time this non-invasive procedure has been ...

More than 2 million adults living in the United States rely on a caregiver's assistance to eat daily meals. In addition to ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Apomorphine helps treat symptoms such as tremors and difficulty in walking, and the continuous delivery would help reduce these so-called "off episodes", where Parkinson's patients experience an ...

“Parkinson’s is a progressive disease. It’s not something you can stabilize. It affects different parts of the body and it’s affected his legs,” she added. “But his voice is as good as ...

Assistive technology like AngelSense has become increasingly popular, offering a cost-effective alternative to constant care while promoting independence for people with disabilities. Straughter ...

It’s about effective design of Assistive Technology, but the design concepts extend far beyond that scope. It’s about making things that are not just functional tools, but objects that are ...

Jan. 21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD) and also reduces "off" time in patients with moderate to ...